ACC Recommendations against the New Coronavirus

The American College of Cardiology (ACC) has launched a document summarizing the potential implications of the new coronavirus identified in Wuhan, China. This new virus has been called COVID-19 by the WHO.

Recomendaciones de la ACC con el nuevo coronavirus

According to the WHO reports, there are around 93000 confirmed cases across the world, and around 12600 are outside China. In Latin America, 16 cases have been diagnosed so far: 6 in Ecuador, 5 in Mexico, 2 in Brazil, 1 in Argentina, 1 in Chile and 1 in the Dominican Republic. 

In this bulletin, the ACC highlights that the cases diagnosed so far indicate patients with comorbidities are at higher risk of complications, even death, if infected with the COVID-19. In fact, 40% of hospitalized cases have a history of cardiovascular or cerebrovascular disease. Some patients have also developed myocarditis.  


Read also: TAVR: Should Transradial Approach be the Second Access Site?


Irrespective of all public health policies to prevent spreading, it seems reasonable to take further safety measures when it comes to CAD patients in places where the virus has become a dramatic concern (basically China). 

Together with the bio-protection measures, we should also adjust secondary prevention protocols, which would provide additional protection (statins, beta-blockers, conversion enzyme inhibitors, aspirin).

These patients should be vaccinated against influenza and pneumococcus.


Read also: What to Do and What Not to Do in Case of PE According to the New European Guidelines.


In places where the COVID-19 is not a threat, we should emphasize prevention against influenza by using vaccines, frequently washing our hands, and adhering to all treatments for all chronic conditions these patients could have. 

Original Title:  ACC clinical bulletin: cardiac implications of novel Wuhan coronavirus (2019-nCoV).

Reference: American College of Cardiology.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Spontaneous Left Main Dissection: Clinical Characteristics, management and Outcomes

Courtesy of Dr. Juan Manuel Pérez. Spontaneous left main dissection in an uncommon, and potentially life-threatening, cause of acute MI. The aim of this study,...

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...

Transcatheter Pulmonary Valve Implantation with a Self-Expanding Valve: Outcomes at 3 Years

Pulmonary regurgitation (PR) is a common condition in patients who have undergone surgical repair of Tetralogy of Fallot or other pathologies involving the right...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACURATE Neo2 Underexpansion: Prevalence and Clinical Implications

While transcatheter aortic valve replacement (TAVR) provides durable clinical benefits across a wide range of patients, technical challenges remain that may affect long-term outcomes....

Spontaneous Left Main Dissection: Clinical Characteristics, management and Outcomes

Courtesy of Dr. Juan Manuel Pérez. Spontaneous left main dissection in an uncommon, and potentially life-threatening, cause of acute MI. The aim of this study,...

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...